Healthcare Beats Tech by 33 Points: Is Wall Street Abandoning AI Too Early?

Something unusual is happening in the US stock market. For years, technology and AI stocks dominated investor attention, while healthcare and consumer staples were often considered slower-growing, defensive investments.

Now the tables have turned.

Investors are moving towards pharmaceutical companies and everyday consumer businesses selling products such as toothpaste, laundry detergent and household essentials. Meanwhile, some of the market’s biggest technology names are struggling to maintain their momentum.

According to Dow Jones Market Data, during the 100 days through November 10, the S&P 500 healthcare sector outperformed information technology by more than 33 percentage points. This was the widest gap since October 2001, following the collapse of the dot-com bubble.

Even more interesting, healthcare was still outperforming technology by more than 22 percentage points as of Wednesday’s close.

This is not just another ordinary sector rotation. It raises a bigger question: Have investors become too pessimistic about AI while paying too much for traditional defensive businesses?

1. Investors are paying for safety, but safety is getting expensive

Healthcare and consumer staples are traditionally attractive during uncertain markets because people continue buying medicine, groceries, toothpaste and household products regardless of economic conditions.

Companies in these sectors often have established brands, relatively predictable demand and more stable earnings.

However, there is a catch: defensive stocks are no longer necessarily cheap.

According to the figures reported by MarketWatch, the technology sector was trading at approximately 16.9 times forward earnings, its lowest valuation since March 2020.

By comparison:

• Information technology: 16.9 times forward earnings.

• Healthcare: 19 times.

• Consumer staples: Nearly 25 times.

This is an unusual reversal of the valuation relationship that dominated much of the past decade.

Investors are paying a significant premium for businesses perceived as safer, while some technology companies are trading at much lower earnings multiples.

2. Is the AI sell-off creating an opportunity?

The recent weakness in technology stocks does not necessarily mean the AI investment cycle is over.

Companies such as Nvidia, AMD and Broadcom remain exposed to the enormous demand for computing infrastructure, AI accelerators and networking equipment.

The market may simply be reassessing how much future growth is already reflected in their share prices.

During the first half of 2026, semiconductor stocks experienced substantial gains. After such a strong run, profit-taking and portfolio rebalancing would not be surprising.

There is also an important distinction between a company experiencing temporary share-price weakness and a business whose competitive position is deteriorating.

If AI demand continues growing while valuations become more reasonable, some technology stocks could become attractive again.

However, investors should not assume every technology stock deserves to recover. Earnings growth, cash flow, competition and capital expenditure still matter.

3. $Wal-Mart(WMT)$  versus $NVIDIA(NVDA)$ ::An unusual valuation comparison

One comparison highlighted in the MarketWatch article particularly caught my attention.

Walmart was trading at a forward P/E ratio above 45, while Nvidia was around 16.

That is a remarkable valuation difference between a major consumer retailer and one of the world’s leading AI chipmakers.

Walmart has a strong retail business, established customer relationships and relatively predictable consumer demand.

Nvidia, meanwhile, operates in a rapidly expanding AI market but faces questions about competition, future infrastructure spending and the sustainability of current growth rates.

The comparison does not automatically make Nvidia the better investment. A lower P/E can reflect genuine business risks, while a higher P/E can reflect confidence in future earnings stability.

But it does challenge the assumption that defensive stocks are always the safer place to put new money.

Sometimes investors pay so much for stability that they overlook opportunities elsewhere.

4. Could this rotation reverse again?

We have seen similar changes in market leadership during 2024 and 2025.

Technology stocks weakened, non-tech sectors attracted attention, and investors began questioning whether the AI trade had peaked. Yet technology subsequently regained momentum.

This time could be different, but the historical pattern is worth remembering.

If earnings expectations for AI companies remain strong and technology valuations become more attractive, institutional investors could gradually return to the sector.

On the other hand, if AI infrastructure spending slows or expected returns fail to materialise, defensive sectors may continue attracting capital.

The key is to distinguish between temporary portfolio rotation and a genuine change in long-term market leadership.

5. How I would position my portfolio

I wouldn’t abandon technology simply because healthcare and consumer staples are outperforming.

Instead, I would look at diversification across different sources of earnings growth.

• Technology: Focus on companies with strong balance sheets, sustainable competitive advantages and genuine AI revenue opportunities.

• Healthcare: Look for businesses with established products, strong cash generation and attractive valuations rather than buying simply because the sector is performing well.

• Consumer staples: Be selective. Stable demand does not automatically justify paying 25 times earnings or more.

• Broad-market ETFs: Maintain diversified exposure rather than trying to predict exactly which sector will lead the next rally.

I would also avoid chasing defensive stocks after a significant run-up. A business can be relatively defensive while still being an expensive investment.

My takeaway

The most interesting part of this rotation is not simply that healthcare is outperforming technology. It is that investors are now paying more for perceived safety while some technology companies are becoming cheaper relative to their expected earnings.

This could eventually create opportunities for investors willing to look beyond short-term market sentiment.

I still believe AI will be an important long-term growth driver, but that does not mean every AI stock is worth buying at any price. Equally, a defensive business is not automatically a bargain just because its earnings are more predictable.

The next phase of the market could reward investors who focus less on which sector is currently popular and more on the relationship between valuation, earnings growth and actual business performance.

Perhaps the biggest investment risk right now is not owning the wrong sector, but paying too much for yesterday’s winners or today’s perceived safe havens.

For discussion purposes only.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
empty
No comments yet